BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 33601250)

  • 1. Actionable data for precision oncology: Framing trustworthy evidence for exploratory research and clinical diagnostics.
    Tempini N; Leonelli S
    Soc Sci Med; 2021 Mar; 272():113760. PubMed ID: 33601250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physician interpretation of genomic test results and treatment selection.
    Brusco LL; Wathoo C; Mills Shaw KR; Holla VR; Bailey AM; Johnson AM; Khotskaya YB; Litzenburger BC; Sanchez NS; Zeng J; Bernstam EV; Eng C; Kee BK; Amaria RN; Routbort MJ; Mills GB; Mendelsohn J; Meric-Bernstam F
    Cancer; 2018 Mar; 124(5):966-972. PubMed ID: 29165790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in precision therapy in pediatric oncology.
    O'Donohue T; Farouk Sait S; Glade Bender J
    Curr Opin Pediatr; 2023 Feb; 35(1):41-47. PubMed ID: 36377257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing Landscape of Clinical-Genomic Oncology Practice.
    Trivedi H; Kling HM; Treece T; Audeh W; Srkalovic G
    Acta Med Acad; 2019 Apr; 48(1):6-17. PubMed ID: 31264429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using biointelligence to search the cancer genome: an epistemological perspective on knowledge recovery strategies to enable precision medical genomics.
    Mousses S; Kiefer J; Von Hoff D; Trent J
    Oncogene; 2008 Dec; 27 Suppl 2():S58-66. PubMed ID: 19956181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementing precision cancer medicine in the genomic era.
    Chen HZ; Bonneville R; Roychowdhury S
    Semin Cancer Biol; 2019 Apr; 55():16-27. PubMed ID: 29857039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Data resources for the identification and interpretation of actionable mutations by clinicians.
    Prawira A; Pugh TJ; Stockley TL; Siu LL
    Ann Oncol; 2017 May; 28(5):946-957. PubMed ID: 28327901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular tumour board at European Institute of Oncology: Report of the first three year activity of an Italian precision oncology experience.
    Repetto M; Crimini E; Boscolo Bielo L; Guerini-Rocco E; Ascione L; Bonfanti A; Zanzottera C; Mazzarella L; Ranghiero A; Belli C; Criscitiello C; Esposito A; Barberis MCP; Curigliano G
    Eur J Cancer; 2023 Apr; 183():79-89. PubMed ID: 36801623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Precision Oncology and "Molecular Tumor Boards" - Concepts, Chances and Challenges].
    Holch JW; Westphalen CB; Hiddemann W; Heinemann V; Jung A; Metzeler KH
    Dtsch Med Wochenschr; 2017 Nov; 142(22):1676-1684. PubMed ID: 29078213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organizing precision medicine: A case study of Memorial Sloan Kettering Cancer Center's engagement in/with genomics.
    Polk JB; Campbell J; Drilon AE; Keating P; Cambrosio A
    Soc Sci Med; 2023 May; 324():115789. PubMed ID: 36996726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enabling Precision Oncology Through Precision Diagnostics.
    Brown NA; Elenitoba-Johnson KSJ
    Annu Rev Pathol; 2020 Jan; 15():97-121. PubMed ID: 31977297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AACR Project GENIE: Powering Precision Medicine through an International Consortium.
    AACR Project GENIE Consortium
    Cancer Discov; 2017 Aug; 7(8):818-831. PubMed ID: 28572459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bringing Precision Medicine to Community Oncologists.
    Cancer Discov; 2017 Jan; 7(1):6-7. PubMed ID: 27864232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical Oncology in the Age of Genomic Medicine.
    Weber TK
    Surg Oncol Clin N Am; 2015 Oct; 24(4):xiii-xv. PubMed ID: 26363545
    [No Abstract]   [Full Text] [Related]  

  • 15. Precision Medicine in Veterinary Science.
    Chon E; Hendricks W; White M; Rodrigues L; Haworth D; Post G
    Vet Clin North Am Small Anim Pract; 2024 May; 54(3):501-521. PubMed ID: 38212188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision Oncology Beyond Genomics: The Future Is Here-It Is Just Not Evenly Distributed.
    Pfohl U; Pflaume A; Regenbrecht M; Finkler S; Graf Adelmann Q; Reinhard C; Regenbrecht CRA; Wedeken L
    Cells; 2021 Apr; 10(4):. PubMed ID: 33920536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer Treatment in the Genomic Era.
    Doherty GJ; Petruzzelli M; Beddowes E; Ahmad SS; Caldas C; Gilbertson RJ
    Annu Rev Biochem; 2019 Jun; 88():247-280. PubMed ID: 30901264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementing the FAIR Data Principles in precision oncology: review of supporting initiatives.
    Vesteghem C; Brøndum RF; Sønderkær M; Sommer M; Schmitz A; Bødker JS; Dybkær K; El-Galaly TC; Bøgsted M
    Brief Bioinform; 2020 May; 21(3):936-945. PubMed ID: 31263868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards.
    Perera-Bel J; Hutter B; Heining C; Bleckmann A; Fröhlich M; Fröhling S; Glimm H; Brors B; Beißbarth T
    Genome Med; 2018 Mar; 10(1):18. PubMed ID: 29544535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic expertise in action: molecular tumour boards and decision-making in precision oncology.
    Bourret P; Cambrosio A
    Sociol Health Illn; 2019 Nov; 41(8):1568-1584. PubMed ID: 31197873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.